日水製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4550/E00971 | Nissui Pharmaceutical Co., Ltd |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2021/06/25 | 日証協 | 23,143株 | +9.68% | 6,143株 | +57.51% | 123,225株 | -2.92% | 2,827株 | -19.87% |
2021/06/18 | 日証協 | 21,100株 | +0.48% | 3,900株 | 0% | 126,925株 | -0.31% | 3,528株 | +45.48% |
2021/06/11 | 日証協 | 21,000株 | -7.89% | 3,900株 | -36.07% | 127,325株 | -2.73% | 2,425株 | -28.89% |
2021/06/04 | 日証協 | 22,800株 | -0.44% | 6,100株 | -12.86% | 130,900株 | +1.88% | 3,410株 | +21.79% |
2021/05/28 | 日証協 | 22,900株 | +18.65% | 7,000株 | +62.79% | 128,490株 | +1.82% | 2,800株 | +27.27% |
2021/05/21 | 日証協 | 19,300株 | +3.21% | 4,300株 | -39.9% | 126,190株 | +2.6% | 2,200株 | -64.52% |
2021/05/14 | 日証協 | 18,700株 | +6.86% | 7,155株 | 0% | 122,990株 | +0.67% | 6,200株 | +135.38% |
2021/05/07 | 日証協 | 17,500株 | -0.76% | 0株 | -100% | 122,166株 | +1.83% | 2,634株 | +192.67% |
2021/04/30 | 日証協 | 17,634株 | -1.12% | 300株 | -89.03% | 119,966株 | +1.27% | 900株 | -89.9% |
2021/04/23 | 日証協 | 17,834株 | -18.19% | 2,734株 | -81.14% | 118,456株 | -7.35% | 8,910株 | -49.69% |
2021/04/16 | 日証協 | 21,800株 | -21.68% | 14,500株 | +190% | 127,856株 | +2.91% | 17,710株 | +63.98% |
2021/04/09 | 日証協 | 27,834株 | -73.92% | 5,000株 | -64.96% | 124,246株 | -35.9% | 10,800株 | -81.67% |
2021/04/02 | 日証協 | 106,734株 | +0.19% | 14,268株 | -49.94% | 193,846株 | +4.53% | 58,907株 | -33.29% |
2021/03/26 | 日証協 | 106,534株 | +3.6% | 28,500株 | +168.87% | 185,446株 | +55.78% | 88,300株 | +2659.38% |
2021/03/19 | 日証協 | 102,834株 | +0.39% | 10,600株 | +82.76% | 119,046株 | -5.4% | 3,200株 | -50.77% |
2021/03/12 | 日証協 | 102,434株 | +2.91% | 5,800株 | -27.81% | 125,846株 | +1.29% | 6,500株 | +25% |
2021/03/05 | 日証協 | 99,534株 | +0.4% | 8,034株 | -31.73% | 124,246株 | +1.14% | 5,200株 | -42.86% |
2021/02/26 | 日証協 | 99,134株 | +0.41% | 11,768株 | +11.36% | 122,846株 | +2.33% | 9,100株 | +435.29% |
2021/02/19 | 日証協 | 98,734株 | +0.29% | 10,568株 | +137.48% | 120,046株 | +0.25% | 1,700株 | -41.38% |
※株式分割は考慮していませんのでご注意ください。